Based on these data, and in accordance with current guidelines, I would use extended adjuvant endocrine therapy in patients with higher risk disease, including node positive, stage III disease, or patients with large or biologically aggressive tumors in the setting of node negative disease <a href=
http://cialis.boats>buy cialis online uk</a>